The Study
Endothelin‐1 impairs glucose transporter trafficking via a membrane‐based mechanism
This study looked at how a chemical affects sugar transport in cells grown in a dish — like watching tiny robots move sugar around in a test tube. It doesn't tell us what happens in people's bodies or if this causes diabetes.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
A chemical called endothelin-1 messes up a tiny fat-cell part called PIP2, which is needed to move sugar transporters (GLUT4) to the cell surface. Without PIP2, sugar can’t get in—even when insulin or salt stress tries to help.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 55 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—this shows how some forms of insulin resistance might start at the cell membrane, not from broken insulin signals, which could lead to new treatments.
- 2Adding back PIP2 fixed the sugar transporters’ movement; blocking PIP2 stopped sugar entry even when insulin or salt was applied.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of Cellular Biochemistry
Year
2006
Authors
A. Strawbridge, J. Elmendorf
Related Content
Claims (7)
Endothelin-1 reduces the ability of insulin to promote glucose uptake into cells by interfering with the cytoskeletal changes that move GLUT4 transporters to the cell surface.
Endothelin-1 decreases PIP2 levels and alters actin organization in fat cells, which prevents GLUT4 from moving to the cell membrane when insulin or high osmolarity signals are present.
Adding phosphatidylinositol 4,5-bisphosphate to fat cells treated with endothelin-1 restores the movement of glucose transporters to the cell surface and reactivates Cbl signaling, showing that loss of this lipid molecule directly causes impaired glucose uptake.
Endothelin-1 reduces the movement of GLUT4 to the cell membrane through a pathway that does not include the insulin signaling proteins IRS-1, PI3K, or Akt-2, leading to insulin resistance at the cellular level.
Endothelin-1 reduces the movement of GLUT4 transporters to the cell membrane during hyperosmotic stress by interfering with a signaling pathway that both insulin and non-insulin signals use, independent of PI3K.
Phosphatidylinositol 4,5-bisphosphate (PIP2) is necessary for the movement of GLUT4 glucose transporters to the cell membrane when cells are exposed to insulin or high osmotic pressure.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.